Thermogenesis Holdings, Inc. (THMO) News
Filter THMO News Items
THMO News Results
Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
---|---|---|---|---|---|---|---|---|---|
Loading, please wait... |
THMO News Highlights
- THMO's 30 day story count now stands at 4.
- Over the past 4 days, the trend for THMO's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
- The most mentioned tickers in articles about THMO are CELL and GENE.
Latest THMO News From Around the Web
Below are the latest news stories about THERMOGENESIS HOLDINGS INC that investors may wish to consider to help them evaluate THMO as an investment opportunity.
ThermoGenesis Holdings, Inc. (NASDAQ:THMO) Q2 2023 Earnings Call TranscriptThermoGenesis Holdings, Inc. (NASDAQ:THMO) Q2 2023 Earnings Call Transcript August 11, 2023 Operator: Good day, and welcome to the ThermoGenesis Holdings conference call and webcast to review financial and operating results for the second quarter ended June 30, 2023. [Operator Instructions]. As a reminder, this conference call is being recorded. I would now like to […] |
Q2 2023 Thermogenesis Holdings Inc Earnings CallQ2 2023 Thermogenesis Holdings Inc Earnings Call |
ThermoGenesis Holdings Announces Second Quarter 2023 Financial Results and Provides Corporate UpdateThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today reported financial and operating results for the second quarter ended June 30, 2023, and provided a corporate business update. |
ThermoGenesis Holdings to Announce Financial Results for the Second Quarter ended June 30, 2023 and Provide a Corporate Strategic UpdateThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced that the Company will release its financial results for the second quarter ended June 30, 2023, and provide a corporate strategic update on Thursday, August 10, 2023, after the close of trading. A conference call and webcast will follow at 1:30 p.m. PT/ 4:30 p.m. ET. |
ThermoGenesis Expands Board of Directors with the Appointments of Dr. Biao Xi and Dr. James XuThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced the appointments of Biao Xi, Ph.D. and James Xu, Esq., DBA, PsyD., J.D., CPA to its Board, effective July 17, 2023. Both are independent directors. The appointments expand ThermoGenesis' Board to seven members. |
Analysts Expect Breakeven For ThermoGenesis Holdings, Inc. (NASDAQ:THMO) Before LongWe feel now is a pretty good time to analyse ThermoGenesis Holdings, Inc.'s ( NASDAQ:THMO ) business as it appears the... |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on TuesdayIt's time for another dive into the latest pre-market stock movers as we check out all of the news moving shares on Tuesday morning! |
Q1 2023 Thermogenesis Holdings Inc Earnings CallQ1 2023 Thermogenesis Holdings Inc Earnings Call |
ThermoGenesis Holdings Announces First Quarter 2023 Financial Results and Provides Corporate UpdateThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today reported financial and operating results for the first quarter ended March 31, 2023 and provided a corporate strategic update. |
ThermoGenesis Holdings to Announce Financial Results for the First Quarter Ended March 31, 2023 and Provide a Corporate Strategic UpdateThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced that the Company will release its financial results for the first quarter ended March 31, 2023 and provide a corporate strategic update on Monday, May 15, 2023, after the close of trading. A conference call and webcast will follow at 1:30 p.m. PT/ 4:30 p.m. ET. |